Dr Rafael Walker -santiago, MD | |
975 Port Washington Rd, Grafton, WI 53024-9201 | |
(262) 329-1000 | |
Not Available |
Full Name | Dr Rafael Walker -santiago |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 13 Years |
Location | 975 Port Washington Rd, Grafton, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366736928 | NPI | - | NPPES |
100103662 | Medicaid | WI | |
036146317 | Other | IL | IL PHYSICIAN LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 69295 (Wisconsin) | Primary |
207X00000X | Orthopaedic Surgery | 69295 (Wisconsin) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Aurora At Home | Milwaukee, WI | Home health agency |
Aurora Medical Center - Grafton | Grafton, WI | Hospital |
Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
Aurora Medical Ctr Washington County | Hartford, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Advanced Healthcare Inc | 3375625833 | 929 |
News Archive
The over-the-counter anti-diarrhea medication Imodium, or its key ingredient loperamide, is increasingly being abused by people attempting to self-treat their opioid addiction, with sometime fatal results.
Boehringer Ingelheim today presented results of the VIVACITO® (NCT01559116) study, the first Phase 3 data to be reported from the TOviTO® clinical trial program, evaluating the effect of the fixed-dose combination of tiotropium and olodaterol (T+O FDC) delivered via the Respimat® inhaler on lung function in people with chronic obstructive pulmonary disease (COPD).
Despite the large volume of information about sports-related concussions on the Internet, many parents and guardians of young athletes have a limited understanding of concussions, according to a study co-authored by a faculty member of UTA's College of Nursing and Health Innovation.
Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.
› Verified 8 days ago
Entity Name | Aurora Advanced Healthcare Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
The over-the-counter anti-diarrhea medication Imodium, or its key ingredient loperamide, is increasingly being abused by people attempting to self-treat their opioid addiction, with sometime fatal results.
Boehringer Ingelheim today presented results of the VIVACITO® (NCT01559116) study, the first Phase 3 data to be reported from the TOviTO® clinical trial program, evaluating the effect of the fixed-dose combination of tiotropium and olodaterol (T+O FDC) delivered via the Respimat® inhaler on lung function in people with chronic obstructive pulmonary disease (COPD).
Despite the large volume of information about sports-related concussions on the Internet, many parents and guardians of young athletes have a limited understanding of concussions, according to a study co-authored by a faculty member of UTA's College of Nursing and Health Innovation.
Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rafael Walker -santiago, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (262) 329-1000 | Dr Rafael Walker -santiago, MD 975 Port Washington Rd, Grafton, WI 53024-9201 Ph: (262) 329-1000 |
News Archive
The over-the-counter anti-diarrhea medication Imodium, or its key ingredient loperamide, is increasingly being abused by people attempting to self-treat their opioid addiction, with sometime fatal results.
Boehringer Ingelheim today presented results of the VIVACITO® (NCT01559116) study, the first Phase 3 data to be reported from the TOviTO® clinical trial program, evaluating the effect of the fixed-dose combination of tiotropium and olodaterol (T+O FDC) delivered via the Respimat® inhaler on lung function in people with chronic obstructive pulmonary disease (COPD).
Despite the large volume of information about sports-related concussions on the Internet, many parents and guardians of young athletes have a limited understanding of concussions, according to a study co-authored by a faculty member of UTA's College of Nursing and Health Innovation.
Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.
› Verified 8 days ago
Eric J. Belin, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Omar J. Darr, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Road, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 | |
Nathan J Kopydlowski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Michael J Anderson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Road, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 | |
Matthew Paul Wichman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 | |
Thomas Michael Doers, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 975 Port Washington Road, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 |